interactionId interactionTypes drugName drugConceptId sources pmids score
92ccce9d-50d2-4115-acf6-8c89b1286876 inhibitor DACOMITINIB chembl:CHEMBL2105719 "TALC, DTC, MyCancerGenome, TdgClinicalTrial, JAX-CKB, ChemblInteractions, CIViC, GuideToPharmacology, CancerCommons, MyCancerGenomeClinicalTrial, PharmGKB, TTD, FDA, OncoKB"  2.07
2661846b-6d23-4a66-9724-cf2c42bc42cf "antibody, suppressor, inhibitor" PANITUMUMAB chembl:CHEMBL1201827 "TALC, ClearityFoundationBiomarkers, MyCancerGenome, TdgClinicalTrial, JAX-CKB, ChemblInteractions, TEND, DoCM, CIViC, GuideToPharmacology, PharmGKB, TTD, FDA"  0.8
35ceb78e-b851-47f6-a629-9932a15e37fb "antagonist, inhibitor" GEFITINIB chembl:CHEMBL939 "TALC, DTC, ClearityFoundationBiomarkers, MyCancerGenome, TdgClinicalTrial, JAX-CKB, ChemblInteractions, TEND, DoCM, COSMIC, CIViC, GuideToPharmacology, MyCancerGenomeClinicalTrial, PharmGKB, TTD, FDA, OncoKB"  0.73
b1a7d3eb-545b-409f-9e56-b0ef0c40009a inhibitor AFATINIB chembl:CHEMBL1173655 "TALC, DTC, MyCancerGenome, TdgClinicalTrial, JAX-CKB, DoCM, COSMIC, CIViC, GuideToPharmacology, MyCancerGenomeClinicalTrial, PharmGKB, FDA, OncoKB"  4.65
c13df633-c7f4-45e8-85e3-bea9d1e10b66 inhibitor OSIMERTINIB chembl:CHEMBL3353410 "MyCancerGenome, JAX-CKB, ChemblInteractions, COSMIC, CIViC, GuideToPharmacology, PharmGKB, TTD, FDA, OncoKB"  2.43
c06ef928-f421-4d0d-ad11-cc15b01c587e  RAMUCIRUMAB chembl:CHEMBL1743062 "PharmGKB, FDA"  0.12
ac4f95b0-af9f-4af6-9fc5-e020f457c3ba  NIVOLUMAB chembl:CHEMBL2108738 "JAX-CKB, CIViC, PharmGKB, FDA"  0.17
e0b2811d-33f0-4eda-b7df-b2e438113710 "antagonist, inhibitor" ERLOTINIB chembl:CHEMBL553 "TALC, DTC, ClearityFoundationBiomarkers, MyCancerGenome, TdgClinicalTrial, ClearityFoundationClinicalTrial, JAX-CKB, TEND, DoCM, COSMIC, CIViC, GuideToPharmacology, CancerCommons, PharmGKB, TTD, FDA, OncoKB"  1.28
398ea41a-6ca8-45f6-acdc-082214fabf65  ATEZOLIZUMAB chembl:CHEMBL3707227 "JAX-CKB, CIViC, PharmGKB, FDA"  0.17
48f7766e-e46d-46fe-a1db-73bb1ffd3d60 "antagonist, antibody, inhibitor" CETUXIMAB chembl:CHEMBL1201577 "TALC, ClearityFoundationBiomarkers, MyCancerGenome, TdgClinicalTrial, JAX-CKB, ChemblInteractions, TEND, DoCM, CIViC, GuideToPharmacology, CancerCommons, TTD, FDA"  0.91
50da864b-393f-499d-becf-fab8cf699a5a  PEMBROLIZUMAB chembl:CHEMBL3137343 "JAX-CKB, CIViC, PharmGKB, FDA"  0.1
